| CAS ID: | 861006-80-6 |
| Molecular Formula: | C46H70O4 |
| Molecular Weight: | 687.1 g/mol |
| Monoisotopic Mass: | 686.5274 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | OMEGA-3-ACID ETHYL ESTERS TYPE A | ICOSAPENT (EPA ETHYL ESTER) | DOCONEXENT (DHA ETHYL ESTER) | TEROMEG | OMEGA-3-ACID ETHYL ESTERS | PRESTYLON | K85 | OMTRYG | OMACOR | LOVAZA | OMEGA-3 MARINE TRIGLYCERIDES | NEBBARO | DUALTIS |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C24H36O2.C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26-4-2;1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18,20-21H,3-4,7,10,13,16,19,22-23H2,1-2H3;5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-;6-5-,9-8-,12-11-,15-14-,18-17- | See All |
| InChI Key: | DTMGIJFHGGCSLO-FIAQIACWSA-N | |
| Smiles: | CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC.CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT03018041 | Disease | Renal fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | January 11, 2017 | Last Verified | January 28, 2019 |
| Sponsor | Joe Chan | ||
Trial Record 2
| ClinicalTrial ID | NCT00760513 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | September 26, 2008 | Last Verified | April 18, 2018 |
| Sponsor | University Hospital Southampton NHS Foundation Trust | ||
| PubChem: | 9831414 |
| ChEMBL: | CHEMBL1200711 |